Shanghai General Healthy Information and Technology Co., Ltd. (SHA:605186)
China · Delayed Price · Currency is CNY 19.95
0.00 (0.00%)
Apr 30, 2026, 3:00 PM CST
SHA:605186 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 345.49 | 288.21 | 274.36 | 298.17 | 473.51 |
Other Revenue | - | 30.13 | 33.2 | 24.19 | 16.25 |
| 345.49 | 318.35 | 307.56 | 322.36 | 489.76 | |
Revenue Growth (YoY) | 8.52% | 3.51% | -4.59% | -34.18% | 70.76% |
Cost of Revenue | 194.58 | 193.88 | 138.97 | 130.31 | 282.38 |
Gross Profit | 150.9 | 124.47 | 168.59 | 192.05 | 207.38 |
Selling, General & Admin | 69.99 | 70.05 | 55.5 | 43.08 | 42.93 |
Research & Development | 21.73 | 21.1 | 23.37 | 22.31 | 22.73 |
Other Operating Expenses | 0.97 | 2.73 | -1.1 | 0.78 | 0.45 |
Operating Expenses | 92.69 | 98.84 | 128.96 | 86.87 | 82.12 |
Operating Income | 58.21 | 25.63 | 39.63 | 105.18 | 125.25 |
Interest Expense | - | -2.81 | -1.11 | - | -0 |
Interest & Investment Income | 2.39 | 1.66 | 15.13 | 6.69 | 5.34 |
Earnings From Equity Investments | - | - | - | - | 2.85 |
Currency Exchange Gain (Loss) | - | -0.37 | -0.04 | 0.03 | -0.33 |
Other Non Operating Income (Expenses) | -40.21 | -0.31 | -0.07 | -0.11 | -0.21 |
EBT Excluding Unusual Items | 20.4 | 23.79 | 53.54 | 111.79 | 132.9 |
Gain (Loss) on Sale of Investments | 14.58 | 9.66 | 11.45 | 13.89 | 3.41 |
Gain (Loss) on Sale of Assets | - | -0.17 | -0.03 | -0 | -0 |
Asset Writedown | -3.45 | - | - | - | - |
Other Unusual Items | - | 3.38 | 2.9 | 6.35 | 7.5 |
Pretax Income | 31.53 | 36.67 | 67.85 | 132.03 | 143.81 |
Income Tax Expense | 5.8 | 4.08 | 5.87 | 12.07 | 16.65 |
Earnings From Continuing Operations | 25.73 | 32.59 | 61.97 | 119.96 | 127.16 |
Minority Interest in Earnings | 5.05 | -0.07 | -1.97 | -4.28 | -9.54 |
Net Income | 30.78 | 32.52 | 60 | 115.68 | 117.62 |
Net Income to Common | 30.78 | 32.52 | 60 | 115.68 | 117.62 |
Net Income Growth | -5.34% | -45.80% | -48.13% | -1.65% | 22.85% |
Shares Outstanding (Basic) | 134 | 136 | 136 | 136 | 137 |
Shares Outstanding (Diluted) | 134 | 136 | 136 | 136 | 137 |
Shares Change (YoY) | -1.23% | -0.63% | 0.20% | -0.49% | 34.28% |
EPS (Basic) | 0.23 | 0.24 | 0.44 | 0.85 | 0.86 |
EPS (Diluted) | 0.23 | 0.24 | 0.44 | 0.85 | 0.86 |
EPS Growth | -4.17% | -45.45% | -48.23% | -1.16% | -8.51% |
Free Cash Flow | 72.26 | -118.93 | -72.47 | -103.98 | -27.54 |
Free Cash Flow Per Share | 0.54 | -0.88 | -0.53 | -0.76 | -0.20 |
Dividend Per Share | - | - | 0.100 | 0.090 | 0.090 |
Dividend Growth | - | - | 11.11% | - | -58.14% |
Gross Margin | 43.68% | 39.10% | 54.82% | 59.58% | 42.34% |
Operating Margin | 16.85% | 8.05% | 12.89% | 32.63% | 25.57% |
Profit Margin | 8.91% | 10.21% | 19.51% | 35.89% | 24.02% |
Free Cash Flow Margin | 20.91% | -37.36% | -23.56% | -32.26% | -5.62% |
EBITDA | 81.69 | 46.14 | 44.49 | 108.56 | 128.49 |
EBITDA Margin | 23.65% | 14.49% | 14.47% | 33.68% | 26.24% |
D&A For EBITDA | 23.48 | 20.51 | 4.86 | 3.38 | 3.23 |
EBIT | 58.21 | 25.63 | 39.63 | 105.18 | 125.25 |
EBIT Margin | 16.85% | 8.05% | 12.89% | 32.63% | 25.57% |
Effective Tax Rate | 18.38% | 11.13% | 8.66% | 9.14% | 11.58% |
Revenue as Reported | - | 318.35 | 307.56 | 322.36 | 489.76 |
Advertising Expenses | - | 0.12 | 0.2 | 0.49 | 0.33 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.